» Articles » PMID: 11373617

Supramolecular Assembly and Acid Resistance of Helicobacter Pylori Urease

Overview
Journal Nat Struct Biol
Specialty Cell Biology
Date 2001 May 25
PMID 11373617
Citations 139
Authors
Affiliations
Soon will be listed here.
Abstract

Helicobacter pylori, an etiologic agent in a variety of gastroduodenal diseases, produces a large amount of urease, which is believed to neutralize gastric acid by producing ammonia for the survival of the bacteria. Up to 30% of the enzyme associates with the surface of intact cells upon lysis of neighboring bacteria. The role of the enzyme at the extracellular location has been a subject of controversy because the purified enzyme is irreversibly inactivated below pH 5. We have determined the crystal structure of H. pylori urease, which has a 1.1 MDa spherical assembly of 12 catalytic units with an outer diameter of approximately 160 A. Under physiologically relevant conditions, the activity of the enzyme remains unaffected down to pH 3. Activity assays under different conditions indicated that the cluster of the 12 active sites on the supramolecular assembly may be critical for the survival of the enzyme at low pH. The structure provides a novel example of a molecular assembly adapted for acid resistance that, together with the low Km value of the enzyme, is likely to enable the organism to inhabit the hostile niche.

Citing Articles

Fungal symbiont transmitted by free-living mice promotes type 2 immunity.

Liao Y, Gao I, Kusakabe T, Lin W, Grier A, Pan X Nature. 2024; 636(8043):697-704.

PMID: 39604728 PMC: 11733984. DOI: 10.1038/s41586-024-08213-2.


Protein interactions in human pathogens revealed through deep learning.

Humphreys I, Zhang J, Baek M, Wang Y, Krishnakumar A, Pei J Nat Microbiol. 2024; 9(10):2642-2652.

PMID: 39294458 PMC: 11445079. DOI: 10.1038/s41564-024-01791-x.


A Urease-Based pH Photoswitch: A General Route to Light-to-pH Transduction.

Ivanov N, Slivkov A, Huck W Angew Chem Int Ed Engl. 2024; 64(3):e202415614.

PMID: 39263723 PMC: 11735890. DOI: 10.1002/anie.202415614.


Molecular design of hydroxamic acid-based derivatives as urease inhibitors of Helicobacter pylori.

Wang N, Wu X, Liang J, Liu B, Wang B Mol Divers. 2024; 28(4):2229-2244.

PMID: 39020133 DOI: 10.1007/s11030-024-10914-9.


Novel therapeutic regimens against : an updated systematic review.

Huang T, Cao Y, Cao L Front Microbiol. 2024; 15:1418129.

PMID: 38912349 PMC: 11190606. DOI: 10.3389/fmicb.2024.1418129.